E1199(c)_2A | R Documentation |
Kaplan-Meier digitized data from E1199(c), figure 2A (PMID 26077235). A reported sample size of 4,954 for a primary endpoint of DFS in breast cancer.
`E1199(c)_2A`
A data frame of 2,483 observations and 3 variables:
time | event time (in years) | |
event | DFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (d1, p3) | |
Sparano JA, Zhao F, Martino S, et al. Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer. J Clin Oncol 2015; 33: 2353–60.
summary(`E1199(c)_2A`)
kmplot(`E1199(c)_2A`)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.